Labeling for Permanent Hysteroscopically-Placed Tubal Implants Intended for Sterilization: Guidance for Industry and Food and Drug Administration Staff

Name: Labeling for Permanent Hysteroscopically-Placed Tubal Implants Intended for Sterilization: Guidance for Industry and Food and Drug Administration Staff
Creator: Food and Drug Administration
Keywords: adverse-events,events,guidances,implants,industry,labeling,reporting,sterilization

Information

Type

Guidance

Regulated products

Medical Devices

Topics

Adverse Event Reporting, Biostatistics, Labeling, Postmarket

Published

October 31, 2016

Last updated

February 9, 2019

Description

This document is a guidance for labeling and adverse event reporting of hysteroscopically-placed tubal implants for sterilization.

Organization

Food and Drug Administration (FDA) 🇺🇸

Country / Region

United States

License

Other (Public Domain)

Feedback

Suggest an improvement to this page

1 Main file

Labeling for Permanent Hysteroscopically-Placed Tubal Implants Intended for Sterilization: Guidance for Industry and Food and Drug Administration Staff

Updated on February 9, 2019

pdf (384.5KB)

URL: https://www.fda.gov/media/96315/download
Permalink: https://data.openrid.co/en/datasets/r/528d3285-a32b-48c6-94ee-05642fd04a0e
MIME Type: application/pdf

Created on: October 31, 2016
Modified on: February 9, 2019

Size: 384.5KB

Labeling for Permanent Hysteroscopically-Placed Tubal Implants Intended for Sterilization: Guidance for Industry and Food and Drug Administration Staff

Information

Type

Regulated products

Topics

Published

Last updated

Description

Tags

Organization

Country / Region

License

Feedback

Actions

Social networks

Embed